Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FC56Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,142
Award facts
- Contract value 100% obligated
- $44,141.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Entresto 24 mg–26 mg tablets (60-count) with a ceiling value of $44,141.66. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. The vendor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion contract vehicle running through December 2026 that supports global pharmaceutical requirements for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal pharmaceutical contracts with the DLA, delivering a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Entresto, a heart failure medication, supports the Defense Logistics Agency's Medical Supply Chain operations to ensure adequate pharmaceutical inventory for military and veteran healthcare needs. The competitive award reflects AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements within the pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DB25FC56Q?
SPE2DB25FC56Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FC56Q worth?
The government has obligated $44,142 on SPE2DB25FC56Q.
Is contract SPE2DB25FC56Q an order under another contract?
Yes. SPE2DB25FC56Q is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC56Q competed?
The extent of competition for SPE2DB25FC56Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award